2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine;6-[3-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-9-yl]benzimidazolo[1,2-c]quinazoline;6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazol-9-yl]benzimidazolo[1,2-c]quinazoline

C100H70BBrN14O2 — CID 157082281

IUPAC2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine;6-[3-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-9-yl]benzimidazolo[1,2-c]quinazoline;6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazol-9-yl]benzimidazolo[1,2-c]quinazoline
SMILESBrc1ccc(-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)cc1.CC1(C)OB(c2ccc3c(c2)c2ccccc2n3-c2nc3ccccc3c3nc4ccccc4n23)OC1(C)C.c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccc5c(c4)c4ccccc4n5-c4nc5ccccc5c5nc6ccccc6n45)cc3)n2)cc1
InChIInChI=1S/C47H29N7.C32H27BN4O2.C21H14BrN3/c1-3-13-31(14-4-1)43-50-44(32-15-5-2-6-16-32)52-45(51-43)33-25-23-30(24-26-33)34-27-28-41-37(29-34)35-17-8-11-21-40(35)53(41)47-49-38-19-9-7-18-36(38)46-48-39-20-10-12-22-42(39)54(46)47;1-31(2)32(3,4)39-33(38-31)20-17-18-27-23(19-20)21-11-6-9-15-26(21)36(27)30-35-24-13-7-5-12-22(24)29-34-25-14-8-10-16-28(25)37(29)30;22-18-13-11-17(12-14-18)21-24-19(15-7-3-1-4-8-15)23-20(25-21)16-9-5-2-6-10-16/h1-29H;5-19H,1-4H3;1-14H
InChIKeyADROJXYKUGXNQU-UHFFFAOYSA-N
MW1590.47 g/mol
LogP23.05
Rot. Bonds10

About 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine;6-[3-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-9-yl]benzimidazolo[1,2-c]quinazoline;6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazol-9-yl]benzimidazolo[1,2-c]quinazoline

2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine;6-[3-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-9-yl]benzimidazolo[1,2-c]quinazoline;6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazol-9-yl]benzimidazolo[1,2-c]quinazoline (PubChem CID 157082281) has the molecular formula C100H70BBrN14O2 and a molecular weight of 1590.47 g/mol. Its IUPAC name is 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine;6-[3-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-9-yl]benzimidazolo[1,2-c]quinazoline;6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazol-9-yl]benzimidazolo[1,2-c]quinazoline.

Molecular Properties

Compound Name2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine;6-[3-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-9-yl]benzimidazolo[1,2-c]quinazoline;6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazol-9-yl]benzimidazolo[1,2-c]quinazoline
PubChem CID157082281
Molecular FormulaC100H70BBrN14O2
Molecular Weight1590.47 g/mol
Exact Mass1588.51
IUPAC Name2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine;6-[3-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-9-yl]benzimidazolo[1,2-c]quinazoline;6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazol-9-yl]benzimidazolo[1,2-c]quinazoline
SMILESBrc1ccc(-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)cc1.CC1(C)OB(c2ccc3c(c2)c2ccccc2n3-c2nc3ccccc3c3nc4ccccc4n23)OC1(C)C.c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccc5c(c4)c4ccccc4n5-c4nc5ccccc5c5nc6ccccc6n45)cc3)n2)cc1
InChIInChI=1S/C47H29N7.C32H27BN4O2.C21H14BrN3/c1-3-13-31(14-4-1)43-50-44(32-15-5-2-6-16-32)52-45(51-43)33-25-23-30(24-26-33)34-27-28-41-37(29-34)35-17-8-11-21-40(35)53(41)47-49-38-19-9-7-18-36(38)46-48-39-20-10-12-22-42(39)54(46)47;1-31(2)32(3,4)39-33(38-31)20-17-18-27-23(19-20)21-11-6-9-15-26(21)36(27)30-35-24-13-7-5-12-22(24)29-34-25-14-8-10-16-28(25)37(29)30;22-18-13-11-17(12-14-18)21-24-19(15-7-3-1-4-8-15)23-20(25-21)16-9-5-2-6-10-16/h1-29H;5-19H,1-4H3;1-14H
InChIKeyADROJXYKUGXNQU-UHFFFAOYSA-N
XLogP23.05
TPSA166.04 Ų
H-Bond Donors
H-Bond Acceptors16
Rotatable Bonds10
Heavy Atoms118
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001590.47
LogP ≤ 523.05
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine;6-[3-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-9-yl]benzimidazolo[1,2-c]quinazoline;6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazol-9-yl]benzimidazolo[1,2-c]quinazoline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine;6-[3-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-9-yl]benzimidazolo[1,2-c]quinazoline;6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazol-9-yl]benzimidazolo[1,2-c]quinazoline?
The IUPAC name of 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine;6-[3-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-9-yl]benzimidazolo[1,2-c]quinazoline;6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazol-9-yl]benzimidazolo[1,2-c]quinazoline (CID 157082281) is 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine;6-[3-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-9-yl]benzimidazolo[1,2-c]quinazoline;6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazol-9-yl]benzimidazolo[1,2-c]quinazoline.
What is the SMILES notation for 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine;6-[3-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-9-yl]benzimidazolo[1,2-c]quinazoline;6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazol-9-yl]benzimidazolo[1,2-c]quinazoline?
The canonical SMILES for 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine;6-[3-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-9-yl]benzimidazolo[1,2-c]quinazoline;6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazol-9-yl]benzimidazolo[1,2-c]quinazoline is Brc1ccc(-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)cc1.CC1(C)OB(c2ccc3c(c2)c2ccccc2n3-c2nc3ccccc3c3nc4ccccc4n23)OC1(C)C.c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccc5c(c4)c4ccccc4n5-c4nc5ccccc5c5nc6ccccc6n45)cc3)n2)cc1.
What is the InChIKey of 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine;6-[3-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-9-yl]benzimidazolo[1,2-c]quinazoline;6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazol-9-yl]benzimidazolo[1,2-c]quinazoline?
The InChIKey is ADROJXYKUGXNQU-UHFFFAOYSA-N. The full InChI is InChI=1S/C47H29N7.C32H27BN4O2.C21H14BrN3/c1-3-13-31(14-4-1)43-50-44(32-15-5-2-6-16-32)52-45(51-43)33-25-23-30(24-26-33)34-27-28-41-37(29-34)35-17-8-11-21-40(35)53(41)47-49-38-19-9-7-18-36(38)46-48-39-20-10-12-22-42(39)54(46)47;1-31(2)32(3,4)39-33(38-31)20-17-18-27-23(19-20)21-11-6-9-15-26(21)36(27)30-35-24-13-7-5-12-22(24)29-34-25-14-8-10-16-28(25)37(29)30;22-18-13-11-17(12-14-18)21-24-19(15-7-3-1-4-8-15)23-20(25-21)16-9-5-2-6-10-16/h1-29H;5-19H,1-4H3;1-14H.
What are the key properties of 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine;6-[3-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-9-yl]benzimidazolo[1,2-c]quinazoline;6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazol-9-yl]benzimidazolo[1,2-c]quinazoline?
2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine;6-[3-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-9-yl]benzimidazolo[1,2-c]quinazoline;6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazol-9-yl]benzimidazolo[1,2-c]quinazoline has a molecular weight of 1590.47 g/mol, XLogP of 23.05, 10 rotatable bonds, 0 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine;6-[3-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]carbazol-9-yl]benzimidazolo[1,2-c]quinazoline;6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazol-9-yl]benzimidazolo[1,2-c]quinazoline is sourced from PubChem (CID 157082281), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).